Morning Homed Blood Pressure Trial in elderly hypertensive patients with olmesartan medoxomil compared to azilsartan

Trial Profile

Morning Homed Blood Pressure Trial in elderly hypertensive patients with olmesartan medoxomil compared to azilsartan

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 10 Jan 2017

At a glance

  • Drugs Olmesartan medoxomil (Primary) ; Azilsartan
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Acronyms MHBP
  • Sponsors Daiichi Sankyo Company
  • Most Recent Events

    • 06 Jan 2017 Status changed from recruiting to active, no longer recruiting.
    • 18 May 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top